Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jur ...

Bio-Techne Corporation (NASDAQ:TECH) Q3 2023 Earnings Conference Call May 3, 2023 9:00 AM ET Company Participants David Clair – Vice President-Investor Relations Chuck Kummeth – Chief Executive Officer Jim Hippel – Chief Financial Officer Conference Call Participants Puneet Souda – SVB Securities Jacob Johnson – Stephens Dan Arias – Stifel Dan Leonard – Credit Suisse Patrick Donnelly – Citi Catherine Schulte – Baird Justin Bowers – Deutsche Bank Alex Nowak – Craig-Hallum Operator Good day, and welcome to th ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other ...

Bio-Techne Corporation (NASDAQ:TECH) Q2 2023 Earnings Conference Call February 2, 2023 9:00 AM ET Company Participants David Clair - Vice President of Investor Relations Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Securities Jacob Johnson - Stephens Dan Arias - Stifel Dan Leonard - Credit Suisse Catherine Schulte - Baird Patrick Donnelly - Citi Justin Bowers - Deutsche Bank Operator Good morning, and welcome to the Bio-Techne E ...

Table of Contents ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022, or Minnesota 41-1427402 (State or other ...

Bio-Techne Corporation (NASDAQ:TECH) Q1 2023 Earnings Conference Call November 1, 2022 9:00 AM ET Company Participants Chuck Kummeth - President, Chief Executive Officer Jim Hippel - Executive Vice President, Chief Financial Officer David Clair - Vice President, Investor Relations Conference Call Participants Puneet Souda - SVB Securities Dan Arias - Stifel Dan Leonard - Credit Suisse Anna - Stephens Alex Nowak - Craig Hallum Catherine Schulte - Baird Patrick Donnelly - Citi Operator Good morning and wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2022, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jurisdiction ...

Bio-Techne Corporation (NASDAQ:TECH) Q4 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Corporate Participants David Clair - Vice President, Investor Relations and Corporate Development Chuck Kummeth - Chief Executive Officer Jim Hippel - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Securities Jacob Johnson - Stephens Dan Arias - Stifel Catherine Schulte - Baird Alex Nowak - Craig-Hallum Patrick Donnelly - Citi Paul Knight - KeyBanc Operator Good morning, and welcome to th ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jur ...

Bio-Techne Corporation (NASDAQ:TECH) Q3 2022 Earnings Conference Call May 4, 2022 9:00 AM ET Company Participants David Clair - Senior Director, IR and Corporate Development Chuck Kummeth - CEO Jim Hippel - CFO Conference Call Participants Dan Arias - Stifel Puneet Souda - SVB Securities Jacob Johnson - Stephens Alex Nowak - Craig-Hallum Catherine Schulte - Baird Patrick Donnelly - Citi Paul Knight - KeyBanc Disclaimer*: This transcript is designed to be used alongside the freely available audio recording o ...